“…Alternatively, to the use of protein antigens, the use of glycan antigens has been explored in the detection of antibodies in VL. Specific IgG antibody efficacy detected in VL by GILPs by ELISA has been reported and has performed well in detecting CVL with subclinical infection (Sampaio et al, 2021). Samples with relative seroconversion in cELISA and dELISA were detected in a lower proportion for IgG anti-PSE and anti-GBC antibodies, in a proportion similar to other studies (de Carvalho et al, 2019).…”